01Apr 2023
Controlling the Uncontrollable: How NUAK1 Governs Centrosome Replication in Pancreatic Cancer

Controlling the Uncontrollable: How NUAK1 Governs Centrosome Replication in Pancreatic Cancer

The NUAK1 protein has been identified as a potential weakness in MYC-dependent cancers, but its role in different cancer types and biological processes is not well understood. Although NUAK inhibitors have been developed, it is unclear when they should be used and what side effects they may have. The researchers investigated the role of NUAK1 in pancreatic ductal adenocarcinoma (PDAC) and found that high NUAK1 expression is associated with reduced overall survival in PDAC patients. Inhibition or depletion of NUAK1 suppresses the growth of PDAC cells in culture by regulating centrosome duplication, but a loss of NUAK1 also triggers genomic instability, which could lead to unwanted genotoxic effects.

  • #oncology

Like

Save

Share